Dogrul, Ahmet <br/><br/>
Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice.  [electronic resource] 

 -  Acta diabetologica  Jun 2011 
 - 135-42 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-5233 
<br/><br/><label>Standard No.: </label>10.1007/s00592-010-0237-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Diabetes Mellitus, Experimental--chemically induced<br/>Diabetic Neuropathies--etiology<br/>Dose-Response Relationship, Drug<br/>Etanercept<br/>Female<br/>Hyperalgesia--etiology<br/>Immunoglobulin G--administration & dosage<br/>Injections, Intravenous<br/>Injections, Spinal<br/>Mice<br/>Mice, Inbred BALB C<br/>Reaction Time--drug effects<br/>Receptors, Tumor Necrosis Factor--administration & dosage<br/>Streptozocin<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors